PDSB

Pds Biotechnology Corp

$1.04+0.11 (11.83%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Edge Therapeutics, Inc. (EDGE) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.

Latest Insider Transactions

Showing 10 of 22 transactions (past 365 days)

PDSB
CEO
Award
$537.8K
Bedu-Addo Frank548,782 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12
PDSB
CSO
Award
$147K
Conn Gregory150,000 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12
PDSB
CFO
Award
$294K
Boesgaard Lars300,000 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12
PDSB
VP
Award
$294K
Brown Spencer D.300,000 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12
PDSB
COO
Award
$294K
Toutain Stephan300,000 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12
PDSB
Director
Award
$53.8K
Freitag Gregory Gene54,876 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12
PDSB
Director
Award
$53.8K
Iliev Ilian54,876 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12
PDSB
Director
Award
$53.8K
Ali-Jackson Kamil54,876 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12
PDSB
Director
Award
$53.8K
Brawley Otis W54,876 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12
PDSB
Director
Award
$53.8K
Glover Stephen C.54,876 shares @ $0.98
Filed 2026-03-03Trade 2026-01-12

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →